Objective: To establish and analyze the reference range of serum thyroid hormone levels in pregnant women in Zhangzhou, and to provide basis for pregnancy examination and subsequent research. Methods: A total of 983 pregnant women with normal antenatal examination in Zhangzhou Hospital from December 2019 to May 2021 were selected as the research objects, including 269 cases in the early pregnancy, 400 cases in the middle pregnancy and 314 cases in the late pregnancy. At the same time, 368 serum samples of healthy non-pregnant women were taken as the non-pregnant control group. The contents of FT3, FT4 and TSH were determined by chemiluminescence immunoassay, and the changes and the range of normal reference values were statistically analyzed. Results: With the development of pregnancy, the serum FT3 and FT4 of pregnant women showed a gradual downward trend. There was no significant difference in FT3 and FT4 levels between the early pregnancy and the non-pregnant control group, respectively, while the middle pregnancy and late pregnancy were significantly lower than those of the non-pregnant control group (P<0.05), and the differences among the three groups during pregnancy were statistically significant (P<0.05). The level of TSH was significantly decreased in the early and middle pregnancy, and was the lowest in the early pregnancy. After that, it gradually increased with the development of pregnancy, and was close to the non-pregnant control group in the late pregnancy (P>0.05). In non-pregnant control group, early pregnancy group, middle pregnancy group and late pregnancy group, the reference ranges of serum FT3 were 3.96-6.16, 4.08-6.20, 3.51-5.86, 3.57-5.53 pmol/L, respectively; the reference ranges of serum FT4 were 8.15-13.59, 8.04-13.34, 6.46-11.60, 6.16-10.66 pmol/L, respectively; the reference values of TSH were 0.58-4.73 mIU/L, 0.33-4.18 mIU/L, 0.33-3.96 mIU/L and 0.47-4.06 mIU/L, respectively. Conclusion: The serum thyroid hormone levels of pregnant women in pregnancy have changed, and the reference ranges of specific thyroid hormone levels in different pregnancy periods in this region are preliminarily established for routine screening of normal pregnancy and subsequent studies.
LIN Meina
,
XU Ruiyuan
,
WANG Erli
,
TANG Zhonghui
,
TENG Shaokang
. Preliminary establishment and analysis of reference range of thyroid hormone levels in pregnant women in Zhangzhou[J]. Journal of Baotou Medical College, 2022
, 38(10)
: 28
-32
.
DOI: 10.16833/j.cnki.jbmc.2022.10.006
[1] LIU H, SHAN Z, LI C, et al. Maternal subclinical hypothyroidism, thyroid auto immunity, and the risk of miscarriage: a prospective cohort study[J]. Thyroid, 2014,24(11):1642-1649.
[2] 刘美艳.妊娠合并甲状腺功能减退的筛查及转归[J].河北医科大学,2013,19(21):109-110.
[3] Frunica RM, Lazarus JH, Gruson D, et al. Update on a new controversy in endocrinology:isolated maternal hypothyrox-inemia[J]. J Endocrinol Invest,2015,38(2): 117-123.
[4] 中华医学会内分泌学分会, 中华医学会围产医学分会. 《妊娠和产后甲状腺疾病诊治指南》 (第2版)[J]. 中华内分泌代谢杂志, 2019, 35(8): 636-655.
[5] 陈玉敏,曾菁,严悦溶,等.成都地区妊娠妇女甲状腺激素正常参考值建立及甲状腺自身抗体对孕妇甲状腺功能的影响[J].四川大学学报(医学版),2017,48(3):450-454.
[6] 万桂英,朱慧芳,陈昇,等.不同妊娠期孕妇甲状腺功能指标参考范围建立[J].中国计划生育学杂志,2020,28(1):131-133.
[7] 许瑞元,黄喆媛,林美娜.不同妊娠期孕妇甲状腺激素水平变化的临床分析[J].包头医学院学报,2020,36(1):4-6,24.
[8] 郑芬萍,李红.解读中国《妊娠和产后甲状腺疾病诊治指南》(第2版)——妊娠期甲状腺毒症诊治部分要点[J].浙江医学,2019,41(22):2353-2355+2360.
[9] 井沆,印倩,张俊,等.贵阳地区妊娠期妇女甲状腺激素参考区间的建立[J].智慧健康,2021,7(7):12-16.
[10] Stagnaro-Green A, Abalovich M, Alexander E,et al.The american thyroid association taskforce on thyroid disease during pregnancy and postpartum. guidelines of the american thyroid association for the diagnosis and management of thyroid disease during pregnancy and postpartum[J].Throid,2011,10:1-45.
[11] 刘艳,陈金玲,丁竟成,等.孕期不同时期血清HCG水平与妊娠期孕妇甲状腺功能减退的相关性[J].实验与检验医学,2020,38(3):544-546,563.
[12] 江夏丽.妊娠合并甲状腺疾病对妊娠结局和新生儿的影响[J].四川解剖学杂志,2020,28(2):30-32.
[13] Soldin OP.Guidelines of the american thyroid association for the diagnosis and management of thyroid disease during pregnancy and postpartum[J].Clin Chem,2011,57:1466-1467.
[14] 中华医学会内分泌学分会,中华医学会围产医学分会. 妊娠和产后甲状腺疾病诊治指南[J].中华内分泌代谢杂志,2012,28(5):354-371.
[15] 冯燕,胡继芬.福州地区妊娠期妇女甲状腺激素水平分析[J].福建医科大学学报,2016,50(3):176-180.
[16] 马丽,陈慧娟,雷婷,等.孕期甲状腺功能相关检测参考范围研究[J].标记免疫分析与临床,2015,22(5):390-393.